Cahilly: Focus on India Masks the Real Data Integrity Problems
This article was originally published in The Gold Sheet
Executive Summary
The problem of data integrity is not so much with a supplier or contract manufacturer halfway around the world, says Monica Cahilly. It’s more about that pdf you just printed from your electronic information system.
You may also be interested in...
Hussain: Empowering Workers is the Key to Data Integrity
Why would pharmaceutical quality personnel fib about something like a batch test? Ajaz Hussain, the former FDA’er who helped launch the 21st Century Quality Paradigm, may have found the answer in the science of human behavioral economics.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.
US FDA, USP Raise Questions About Valisure’s Assertions Of Benzoyl Peroxide’s Benzene Risks
The US drug regulatory authority and standard-setting organization are evaluating the drug-screening venture’s findings regarding stability and potential carcinogenic risks associated with the widely used acne treatment, which includes Rx formulations.